Abcellera Biologics is trading at $11.81, down 4.56% in pre-market on October 15 amid broader risk-off sentiment after hotter-than-expected U.S. inflation raised rate-hike concerns.
- Reuters reported the inflation surprise weighed on global equities and technology shares; Nasdaq futures also fell, adding to the weak market backdrop.
- No fresh company announcement dated October 14 or 15 appeared on the company’s news-release page. No volume or activity data was provided.